Skip to content
10-Q

Quarterly Report

AMERICAN BIO MEDICA CORPORATION

0001654954-21-012429

← back to feed
Filed
Nov 18, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 18, 2021 47.6M sh
Cash And Equivalents Q3 2021 · Sep 30, 2021 $41K
Cash And Equivalents Q3 2021 · Dec 31, 2020 $98K
Cash And Equivalents Q3 2021 · Sep 30, 2020 $61K
Cash And Equivalents Q3 2021 · Dec 31, 2019 $4K
Current Liabilities Q3 2021 · Sep 30, 2021 $2.99M
Current Liabilities Q3 2021 · Dec 31, 2020 $2.02M
Total Liabilities Q3 2021 · Sep 30, 2021 $3M
Total Liabilities Q3 2021 · Dec 31, 2020 $3.18M
Current Assets Q3 2021 · Sep 30, 2021 $1.61M
Current Assets Q3 2021 · Dec 31, 2020 $1.18M
Total Assets Q3 2021 · Sep 30, 2021 $2.28M
Total Assets Q3 2021 · Dec 31, 2020 $1.93M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$299K
Sga Expense Q3 2021 · Sep 30, 2020 $294K
Sga Expense Q3 2021 · Sep 30, 2020 $951K
Rd Expense Q3 2021 · Sep 30, 2020 $24K
Rd Expense Q3 2021 · Sep 30, 2020 $77K
Net Income Q3 2021 · Sep 30, 2020 −$216K
Net Income Q3 2021 · Sep 30, 2020 −$563K
Operating Income Q3 2021 · Sep 30, 2020 −$172K
Operating Income Q3 2021 · Sep 30, 2020 −$428K
Gross Profit Q3 2021 · Sep 30, 2020 $235K
Gross Profit Q3 2021 · Sep 30, 2020 $1.01M
Cost Of Revenue Q3 2021 · Sep 30, 2020 $648K
Cost Of Revenue Q3 2021 · Sep 30, 2020 $2.36M
Revenue Q3 2021 · Sep 30, 2020 $883K
Revenue Q3 2021 · Sep 30, 2020 $3.37M